$EDIT 4 SEC Filings

Filed On	Filing
09 Sep 2026	Form 4: Ory Daniel Scott, EVP, Chief Medical Officer Granted 950,000 Stock Option (right to buy)
04 Sep 2026	Form 4: Parison Amy, SVP, Chief Financial Officer Sold 453 shares ($1.38K)
04 Sep 2026	Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER Sold 709 shares ($2.15K)
04 Sep 2026	Form 4: O'Neill Gilmore Neil, Director Sold 5,124 shares ($15.6K)
07 Aug 2026	Form 4: Ellinor Patrick Thomas Ii, Director Granted 103,400 Stock Option (right to buy)
05 Aug 2026	Form 4: Parison Amy, SVP, Chief Financial Officer Sold 678 shares ($1.75K)
29 Jul 2026	Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER Sold 4,928 shares ($13.2K)
22 Jun 2026	Form 4: Connaughton Bernadette, Director Granted 51,700 Stock Option (right to buy)
22 Jun 2026	Form 4: Hopfield Jessica, Director Granted 51,700 Stock Option (right to buy)
22 Jun 2026	Form 4: Hirsch Andrew, Director Granted 51,700 Stock Option (right to buy)
22 Jun 2026	Form 4: Scadden David, Director Granted 51,700 Stock Option (right to buy)
22 Jun 2026	Form 4: Levy Elliott M., Director Granted 51,700 Stock Option (right to buy)
05 Jun 2026	Form 4: Parison Amy, SVP, Chief Financial Officer Sold 464 shares ($1.25K)
05 Jun 2026	Form 4: O'Neill Gilmore Neil, Director Sold 15,380 shares ($41.5K)
05 Jun 2026	Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER Sold 731 shares ($1.97K)
16 Mar 2026	Form 4: O'Neill Gilmore Neil, Director Granted 1,015,200 Stock Option (right to buy)
16 Mar 2026	Form 4: Parison Amy, SVP, Chief Financial Officer Granted 292,856 Stock Option (right to buy)
16 Mar 2026	Form 4: Burkly Linda, EVP, CHIEF SCIENTIFIC OFFICER Granted 292,856 Stock Option (right to buy)
04 Mar 2026	Form 4: O'Neill Gilmore Neil, Director Sold 5,394 shares ($10.9K)
04 Mar 2026	Form 4: Parison Amy, SVP, Chief Financial Officer Sold 474 shares ($957)

Comments